Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

To Build and Evaluate a Precise Diagnosis, Therapy Assessment and Prognosis Prediction Model of Breast Cancer Based on Artificial Intelligence

NCT04270032 is registered in ClinicalTrials.gov with The First Affiliated Hospital of the Fourth Military Medical University as lead sponsor.

NCT NCT04270032
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04270032 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
To Build and Evaluate a Precise Diagnosis, Therapy Assessment and Prognosis Prediction Model of Breast Cancer Based on Artificial Intelligence
Lead sponsor
The First Affiliated Hospital of the Fourth Military Medical University
Phase
Observational
Overall status
Unknown status
Start date
February 1, 2020
Completion date
September 1, 2024
Enrollment
10,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer